1. YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress
   Si‐Yao Qu et al, 2017, Cancer Medicine CrossRef
2. YY1 regulates melanoma tumorigenesis through a miR-9 ~ RYBP axis
   Guowei Zhao et al, 2015, Journal of Experimental & Clinical Cancer Research CrossRef
3. RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity
   Roni Touboul et al, 2021, Cancers CrossRef
4. Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: A therapeutic target
   Benjamin Bonavida et al, 2015, Pharmacology & Therapeutics CrossRef
5. YY1 regulates cancer cell immune resistance by modulating PD-L1 expression
   Emily Hays et al, 2019, Drug Resistance Updates CrossRef
6. Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer
   Stephanie Wottrich et al, 2017, Drug Resistance Updates CrossRef
7. miR-34a inhibits the migration and invasion of esophageal squamous cell carcinoma by targeting Yin Yang-1
   JIHUA NIE et al, 2015, Oncology Reports CrossRef
8. Participation of different miRNAs in the regulation of YY1: Their role in pathogenesis, chemoresistance, and therapeutic implication in hematologic malignancies
   Mario Morales-Martinez et al, 2021, YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer CrossRef
9. RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact
   Apostolos Zaravinos et al, 2018, Cancers CrossRef
10. The Two Sides of YY1 in Cancer: A Friend and a Foe
    Sailu Sarvagalla et al, 2019, Frontiers in Oncology CrossRef
11. Diagnostic and prognostic relevance of CP2c and YY1 expression in hepatocellular carcinoma
    Ji Sook Kim et al, 2017, Oncotarget CrossRef
12. Therapeutic targeting of SNAIL, RKIP, and YY1 in tumor metastasis and drug resistance
    Nadire Özenver et al, 2020, Prognostic and Therapeutic Applications of RKIP in Cancer CrossRef
13. Yin Yang 1 regulation of tumor cell resistance to chemotherapeutic drugs
    Tania V. Lopez-Perez et al, 2021, YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer CrossRef
14. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome
    Martí Duran-Ferrer et al, 2020, Nature Cancer CrossRef
15. Understanding Mechanisms of RKIP Regulation to Improve the Development of New Diagnostic Tools
    Massimo Papale et al, 2022, Cancers CrossRef
16. Nitric Oxide Donors Sensitize Resistant Cancer Cells to Apoptosis Induced by Chemotherapy: Molecular Mechanisms of Sensitization
    Benjamin Bonavida, 2017, Nitric Oxide as a Chemosensitizing Agent CrossRef
17. Molecular mechanisms of YY1 overexpression in human cancers and its prognostic significance
    Gabriele Michele et al, 2021, YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer CrossRef
18. Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions
    Rendy Hosea et al, 2023, Cancers CrossRef
19. METTL3 facilitates multiple myeloma tumorigenesis by enhancing YY1 stability and pri-microRNA-27 maturation in m6A-dependent manner
    Feifei Che et al, 2023, Cell Biology and Toxicology CrossRef
20. Yin Yang 1 expression predicts a favourable survival in diffuse large B-cell lymphoma
    Tian Xue et al, 2024, Heliyon CrossRef
21. CRHR2/Ucn2 signaling is a novel regulator of miR‐7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas‐mediated apoptosis
    Charalabos Pothoulakis et al, 2018, International Journal of Cancer CrossRef